April 29, 2016 /
Click here to receive MS news via e-mail
Mabthera (rituximab), a widelyapproved drug for treating lymphoma and/or rheumatoid arthritis, is highly
effective in treating multiple sclerosis (MS), researchers reported in an
observational study in Sweden, where Mabthera is increasingly being used outside
of its approved indications to treat relapsing-remitting MS patients. The
study, published in the journal Annals of Neurology, is titled “Rituximab
[…]
The post Lymphoma Drug, Rituximab, Highly Effective in Treating
Relapsing MS, Study from Sweden Reports appeared first on Multiple Sclerosis News Today.
Relapsing MS, Study from Sweden Reports appeared first on Multiple Sclerosis News Today.
Read on »
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News
Provides educational information, resources and services for those affected by MS
We Believe YOU (the MS Patients and Caregivers) should Be Empowered with Multiple Sclerosis information
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT

